+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Ocular Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768114
  • Report
  • April 2019
  • Region: Global
  • 60 pages
  • VPA Research

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celldex Therapeutics Inc
  • Delcath Systems Inc
  • Eli Lilly and Co
  • Exelixis Inc
The global clinical trial report- “2019 Ocular Melanoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Melanoma. It presents in-depth analysis of Ocular Melanoma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ocular Melanoma.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ocular Melanoma clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ocular Melanoma

The research work is prepared through extensive and continuous research on Ocular Melanoma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ocular Melanoma patients are identified
  • The report includes panorama of Ocular Melanoma clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ocular Melanoma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celldex Therapeutics Inc
  • Delcath Systems Inc
  • Eli Lilly and Co
  • Exelixis Inc
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ocular Melanoma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ocular Melanoma Clinical Trials by Region
2.2.2 Average Enrollment of Ocular Melanoma Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ocular Melanoma Treatment, 2019

3. Region wise Ocular Melanoma Clinical Trials
3.1 Asia Pacific Ocular Melanoma Clinical Trials by Country
3.2 Europe Ocular Melanoma Clinical Trials by Country
3.3 North America Ocular Melanoma Clinical Trials by Country
3.4 Middle East and Africa Ocular Melanoma Clinical Trials by Country
3.5 South and Central America Ocular Melanoma Clinical Trials by Country

4. Ocular Melanoma Clinical Trial Trends
4.1 Start Year wise Ocular Melanoma Clinical Trials
4.2 Phase wise Ocular Melanoma Clinical Trials
4.3 Trial Status wise Ocular Melanoma Clinical Trials
4.4 Trial Type wise Ocular Melanoma Clinical Trials

5. Ocular Melanoma Average Enrollment Trends
5.1 Average Enrollment in Ocular Melanoma Trials by Year
5.2 Average Enrollment in Ocular Melanoma Trials by Phase
5.3 Average Enrollment in Ocular Melanoma Trials by Status
5.4 Average Enrollment in Ocular Melanoma Trials by Type of Trial

6. Companies Participating in Ocular Melanoma Clinical Trials
6.1 Ocular Melanoma Trials by Sponsor Type
6.2 Ocular Melanoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ocular Melanoma Trials- Phase 1
7.2 Ocular Melanoma Trials- Phase 2
7.3 Ocular Melanoma Trials- Phase 3
7.4 Ocular Melanoma Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ocular Melanoma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ocular Melanoma Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ocular Melanoma Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ocular Melanoma Clinical Trials and Enrolment
Figure 7: North America - Country wise Ocular Melanoma Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ocular Melanoma Clinical Trials and Enrolment
Figure 9: Ocular Melanoma Clinical Trials by Phase
Figure 10: Ocular Melanoma Clinical Trials by Trial Status
Figure 11: Ocular Melanoma Clinical Trials by Type
Figure 12: Ocular Melanoma Clinical Trials by Sponsor Type
Figure 13: Ocular Melanoma Clinical Trials by Leading Sponsors
Figure 14: Ocular Melanoma Average Enrollment by Phase
Figure 15: Ocular Melanoma Average Enrollment by Trial Status
Figure 16: Ocular Melanoma Average Enrollment by Type
Figure 17: Ocular Melanoma- Average Enrolment by Type of Sponsors
Figure 18: Ocular Melanoma- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Ocular Melanoma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ocular Melanoma Clinical Trials and Enrolment
Table 5: Europe - Country wise Ocular Melanoma Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ocular Melanoma Clinical Trials and Enrolment
Table 7: North America - Country wise Ocular Melanoma Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ocular Melanoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ocular Melanoma Average Enrollment by Phase
Table 15: Ocular Melanoma Average Enrollment by Trial Status
Table 16: Ocular Melanoma Average Enrollment by Type
Table 17: Ocular Melanoma- Average Enrolment by Type of Sponsors
Table 18: Ocular Melanoma- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celldex Therapeutics Inc
  • Delcath Systems Inc
  • Eli Lilly and Co
  • Exelixis Inc
  • Immunocore Ltd
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
Note: Product cover images may vary from those shown
Adroll
adroll